spacer
home > ebr > winter 2003 > the chemical synthesis of proteins: beyond the genome
PUBLICATIONS
European Biopharmaceutical Review

The Chemical Synthesis of Proteins: Beyond the Genome

The pivotal role of proteins in biological processes and disease, and the increasing success of protein therapeutics, has led to the increased development of technologies for their production. In particular, the incorporation of unnatural amino acids and chemical modifications into proteins has enabled a wide variety of derivatives to be rationally engineered for applications in all facets of basic research, drug discovery, diagnostics and therapeutics. The ability to engineer protein sequences in a site-specific manner is thus highly prized and opens up many powerful new avenues.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Graham Cotton, PhD, Senior Research Scientist at Albachem Ltd

Dr Graham Cotton received his BSc in Chemistry from Durham University and gained his PhD at the University of Edinburgh in the field of synthetic peptide vaccines and therapeutics. Having continued these studies as a Postdoctoral Worker, he moved to Rockefeller University, New York in 1996, where he spent over four years as a Postdoctoral Fellow developing novel protein engineering technologies and their application for elucidating the molecular events regulating cell signalling processes. He then joined Amersham Biosciences to further develop this research area before moving to Albachem Ltd in 2002. As Senior Research Scientist, he is applying his multi-disciplinary experience to focus on new chemical and biological approaches to protein therapeutics.

spacer
Dr Graham Cotton
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement